Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02625220 · ClinicalTrials.gov registry record · NA
Dispensing Evaluation of Investigational Contact Lenses
A NA study of Myopia; Astigmatism, sponsored by Johnson & Johnson Vision Care.
- Completed
- Registry status
- NA
- Development phase
- 177
- Enrollment target
- 12
- Study locations
NCT02625220: Completed NA study of Myopia; Astigmatism, sponsored by Johnson & Johnson Vision Care.
NCT02625220 is a NA study of Myopia; Astigmatism that has completed, run by Johnson & Johnson Vision Care. The registered enrollment target is 177 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02625220, a NA study of Myopia; Astigmatism, has completed, sponsored by Johnson & Johnson Vision Care.
- COMPLETED
- Registry status
- NA
- Development phase
- 177 participants
- Enrollment target
- 12
- Study locations
Study Summary
Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.
Primary Outcome
Monocular visual acuity was assessed using distance Snellen visual acuity. Visual Acuity data was dichotomized such that 'response=1' if a subjects has 20/40 or better and 'response=0' if subject has worse than 20/40. The proportion of eyes with 20/40 or better was reported.
Conditions Studied
Interventions
- DEVICE Prototype toric lens senofilcon A
Study Locations (12)
Florida
- Edward S. Wygonik, OD - Jacksonville
- The Eye Center - Pembroke Pines
- Eye Associates of Winter Park - Winter Park
Ohio
- New Image Eye Center - Springfield
- Professional Vision Care - Westerville
Illinois
- Eyecare Associates - Bloomington
Indiana
- Indiana University College of Optometry - Bloomington
Kansas
- Kannarr Eye Care - Pittsburg
New Mexico
- ABQ Eyecare - Albuquerque
New York
- Sacco Eye Group - Vestal
Rhode Island
- West Bay Eye Associates - Warwick
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 177 participants |
| Start Date | 2015-10 |
| Est. Completion | 2015-11 |
| Phase | NA |
What the finished NCT02625220 record still lists
NCT02625220 is an interventional study that assigns participants to a tested intervention. The registered 177 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Myopia; Astigmatism appearing as the primary indexed condition, and to 1 intervention - of which Prototype toric lens senofilcon A is the first listed.
NCT02625220 lists 12 locations in 9 states (Florida, Ohio, Illinois).
Frequently Asked Questions
What is clinical trial NCT02625220 about?
NCT02625220 is a clinical study titled "Dispensing Evaluation of Investigational Contact Lenses". Non-randomized, single-masked, 2-visit, bilateral wear, single-arm dispensing study to evaluate the visual acuity, rotational performance, lens fit, stability and subjective characteristics of a senofilcon-based JJVCI investigational toric contact lens design.
What is the current status of trial NCT02625220?
This trial is currently completed. It is a NA study. The enrollment target is 177 participants. The study started on 2015-10. Estimated completion is 2015-11.
What conditions does trial NCT02625220 study?
This clinical trial studies the following conditions: Myopia; Astigmatism.
What interventions are being tested in trial NCT02625220?
The interventions under investigation include: Prototype toric lens senofilcon A (DEVICE).
Who is sponsoring clinical trial NCT02625220?
This trial is sponsored by Johnson & Johnson Vision Care, which has 142 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02625220 being conducted?
This trial has 12 study locations across Florida, Illinois, Indiana, Kansas, New Mexico. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02625220's enrollment target sits among peer trials
177 604th of 2000 higher than 1,396 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05491551 · 177 participants · NA
Alcohol-ROC-Training
- NCT06108050 · 177 participants · Phase 1
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in Adults With Advanced/Metastatic Solid Tumors
- NCT06575712 · 177 participants · NA
Coping Skills Training for Symptom Management and Daily Steps (Step Up)
- NCT06674980 · 177 participants · NA
Clinical Trial Assessing Human Placental Membrane Products and Standard of Care Versus Standard of Care in Nonhealing DFUs and VLUs
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia